DAYHOFF LABS
Live / Applied — First extension granted (statement of use) (as of 07 Oct 2025)
What this means for you
Not registered yet, but its 27 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97910519
- Mark type
- Stylized text
- Filed
- 27 Apr 2023
- Published for opposition
- 11 Feb 2025
- Attorney of record
- Lisa A. Pieroni
Goods and services
- Class 001 — Chemicals: Biochemical preparations for scientific purposes; Chemical preparations for use in the biochemical and chemical industry; Diagnostic reagents for use in the biochemistry, clinical chemistry and bio-engineering industries; reagents for research purposes; reagents for testing biological samples and biochemical preparations for scientific research purposes
- Class 005 — Pharmaceuticals: Chemical reagents for medical purposes; diagnostic preparations for medical purposes; biological preparations in the nature of bio-engineered pharmaceutical preparations for the treatment of metabolic disorders
- Class 009 — Scientific and electric apparatus: Medical laboratory research instruments for use in bio-engineering; downloadable computer software for use in bio-engineering and bioinformatics for designing molecules, predicting properties of molecules and designing molecular synthesis and applications in synthetic biology; computer hardware for detecting labeled molecule and analyzing genetic data and bioinformatics; computer hardware and embedded computer software for designing molecules, predicting properties of molecules and designing molecular synthesis and applications in synthetic biology for use in bio-engineering; downloadable computer software for use in bio-engineering and bioinformatics for designing molecules, predicting properties of molecules and designing molecular synthesis and applications in synthetic biology.
- Class 042 — Scientific and technological services: Chemical, biochemical, biological and bio-engineering research and analysis; diagnostic services in the field of biochemistry and bio-engineering in the nature of contract research and development, bioengineering, bioprospecting, biocatalyst discovery and design, development of reagents, and processes for synthetic biology applications; diagnostic services in the field of artificial intelligence driven bio-engineering in the nature of contract research and development, bioengineering, bioprospecting, biocatalyst discovery and design, development of reagents, and processes for synthetic biology applications; software as a service (SaaS) services featuring software for analyzing genetic data, bioinformatics and biochemical pathways; software as a service (SaaS) services, namely, hosting software for use by others for use analyzing genetic data, bioinformatics, bio-engineering and metabolic pathways; providing on-line non-downloadable software using artificial intelligence for computational biochemistry and chemistry
Owner
- DAYHOFF LABS, INC., WILMINGTON, DE, US
- DAYHOFF LABS, INC., WILMINGTON, DE, US
- Eigen Labs, Inc., Wilmington, DE, US
Prosecution history
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2025 — SOU EXTENSION 1 GRANTED
- 07 Oct 2025 — SOU EXTENSION 1 FILED
- 07 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2025 — PUBLISHED FOR OPPOSITION
- 05 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Oct 2024 — NON-FINAL ACTION E-MAILED
- 29 Oct 2024 — NON-FINAL ACTION WRITTEN